Trident Texofab Ltd.BSE: TTFL

Shareholder information - receipt of in-principle approval granted by the stock exchange for the issue of upto 60,00,000 warrants convertible into 60,00,000 equity shares of rs. 10/- each at a price not less than rs. 70/- each to non-promoters on a p

· Issued by Trident Texofab Ltd. via BSE India

Pursuant to Regulation 28(1) and 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, we wish to inform you that the BSE Limited vide its letter LOD/PREF/TT/FIP/1481/2024-25 dated December 10, 2024 has granted In-Principle approval for the Issue of upto 60,00,000 convertible warrants into 60,00,000 equity shares of Rs. 10/- each to non-promoters on a Preferential basis.

View Attachment

View original source (BSE India)Trident Texofab Ltd. on 6ix

Earlier from Trident Texofab

Later from Trident Texofab

All Trident Texofab news releases